Publikationen von Miloslav Sanda

Cho, H.; Lai, C.-C.; Bonnavion, R.; Alnouri, M. W.; Wang, S.; Roquid, K. A.; Kawase, H.; Campos, D.; Chen, M.; Weinstein, L. S. et al.; Martinez, A.; Looso, M.; Sanda, M.; Offermanns, S.: Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes. SCIENCE 387 (6734), S. 674 - 682 (2025)

Cho, H.; Lai, C.-C.; Bonnavion, R.; Alnouri, M. W.; Wang, S.; Roquid, K. A.; Kawase, H.; Campos, D.; Chen, M.; Weinstein, L. S. et al.; Martinez, A.; Looso, M.; Sanda, M.; Offermanns, S.: Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes. SCIENCE 387 (6734), S. 674 - 682 (2025)

Xu, Y.; Gehlot, R.; Capon, S. J.; Albu, P. M.; Gretz, J.; Bloomekatz, J.; Mattonet, K.; Vucicevic, D.; Talyan, S.; Kikhi, K. et al.; Guenther, S.; Looso, M.; Firulli, B. A.; Sanda, M.; Firulli, A. B.; Lacadie, S. A.; Yelon, D.; Stainier, D. Y. R.: PDGFRA is a conserved HAND2 effector during early cardiac development. NATURE CARDIOVASCULAR RESEARCH 3 (12) (2024)

Xu, Y.; Gehlot, R.; Capon, S. J.; Albu, M.; Gretz, J.; Bloomekatz, J.; Mattonet, K.; Vucicevic, D.; Talyan, S.; Kikhi, K. et al.; Guenther, S.; Looso, M.; Firulli, B. A.; Sanda, M.; Firulli, A. B.; Lacadie, S. A.; Yelon, D.; Stainier, D. Y. R.: PDGFRA is a conserved HAND2 effector during early cardiac development. NATURE CARDIOVASCULAR RESEARCH 3 (12) (2024)

Girgis, M.; Petruncio, G.; Russo, P.; Peyton, S.; Paige, M.; Campos, D.; Sanda, M.: Analysis of N- and O-linked site-specific glycosylation by ion mobility mass spectrometry: State of the art and future directions. PROTEOMICS (2024)

Campos, D.; Girgis, M.; Yang , Q.; Zong, G.; Goldman, R.; Wang , L.-X.; Sanda, M.: "Ghost" Fragment Ions in Structure and Site-Specific Glycoproteomics Analysis. ANALYTICAL CHEMISTRY (Volume 95, Issue 27), S. 10145 - 10148 (2023)

Benicky, J.; Sanda, M.; Panigrahi, A.; Liu, J.; Wang, Z.; Pagadala, V.; Su, G.; Goldman, R.: A 6-O-endosulfatase activity assay based on synthetic heparan sulfate oligomers. GLYCOBIOLOGY (2023)

Selvanesan, B. C.; Varghese, S.; Andrys-Olek, J.; Arriaza, R. H.; Prakash, R.; Tiwari, P. B.; Hupalo, D.; Gusev, Y.; Patel, M. N.; Contente, S. et al.; Sanda, M.; Uren, A.; Wilkerson, M. D.; Dalgard, C. L.; Shimizu, L. S.; Chruszcz, M.; Borowski, T.; Upadhyay, G.: Lymphocyte antigen 6K signaling to aurora kinase promotes advancement of the cell cycle and the growth of cancer cells, which is inhibited by LY6K-NSC243928 interaction. CANCER LETTERS 558, 216094 (2023)

Sanda, M.; Yang, Q.; Zong, G.; Chen, H.; Zheng, Z.; Dhani, H.; Khan, K.; Kroemer, A.; Wang, L.-X.; Goldman, R.: LC-MS/MS-PRM Quantification of IgG Glycoforms Using Stable Isotope Labeled IgG1 Fc Glycopeptide Standard. JOURNAL OF PROTEOME RESEARCH (2023)

Panigrahi , A.; Zhang, L.; Benicky , J.; Sanda, M.; Ahn, J.; Goldman, R.: A multiplexed microflow LC-MS/MS-PRM assay for serologic quantification of IgG N- and HPX O- glycoforms in liver fibrosis. SCIENTIFIC REPORTS 13 (1) (2023)

Panigrahi, A.; Zhang, L.; Benicky, J.; Sanda, M.; Ahn, J.; Goldman, R.: A multiplexed microflow LC-MS/MS-PRM assay for serologic quantification of IgG N- and HPX O-glycoforms in liver fibrosis. SCIENTIFIC REPORTS 13 (1), 606 (2023)

Campos, D.; Girgis, M.; Sanda, M.: Site-specific glycosylation of SARS-CoV-2: Big challenges in mass spectrometry analysis. PROTEOMICS, e2100322 (2022)

Panigrahi, A.; Benicky, J.; Wei, R.; Ahn, J.; Goldman, R.; Sanda, M.: A Rapid LC-MS/MS-PRM Assay for Serologic Quantification of Sialylated O-HPX Glycoforms in Patients with Liver Fibrosis. MOLECULES 27 (7), 2213 (2022)